Issue Information ‐ Editorial Board
Issue Information ‐ TOC1
Issue Information ‐ TOC2
Issue Information ‐ Papers to be published in forthcoming issues
Glomerular infiltration by intravascular large B‐cell lymphoma
Cutaneous hyperpigmentation and cobalamin deficiency
What is known and unknown about chemotherapy‐related cognitive impairment in patients with haematological malignancies and areas of needed research
Recent advances in the understanding of myelodysplastic syndromes with ring sideroblasts
Phase II trial of ofatumumab plus ESHAP (O‐ESHAP) as salvage treatment for patients with relapsed or refractory classical Hodgkin lymphoma after first‐line chemotherapy
Short‐ and long‐term outcomes of AL amyloidosis patients admitted into intensive care units
Multiplex polymerase chain reaction‐based prognostic models in diffuse large B‐cell lymphoma patients treated with R‐CHOP
Langerhans cell histiocytosis
Efficacy of the GemOx‐R regimen leads to the identification of Oxaliplatin as a highly effective drug against Mantle Cell Lymphoma
Evaluation of B cell maturation antigen as a target for antibody drug conjugate mediated cytotoxicity in multiple myeloma
Clinicopathological features of histological transformation from extranodal marginal zone B‐cell lymphoma of mucosa‐associated lymphoid tissue to diffuse large B‐cell lymphoma
Elevated levels of macromolecular damage are correlated with increased nitric oxide synthase expression in erythrocytes isolated from twin neonates
Post‐thaw viability of cryopreserved peripheral blood stem cells (PBSC) does not guarantee functional activity
Four decades of stem cell transplantation for Fanconi anaemia in the Netherlands
Loss of PUMA (BBC3) does not prevent thrombocytopenia caused by the loss of BCL‐XL (BCL2L1)
VLA‐4 blockade by natalizumab inhibits sickle reticulocyte and leucocyte adhesion during simulated blood flow
Impact of therapy in a cohort of unselected children with Down Syndrome‐associated Acute Lymphoblastic Leukaemia
From CLL to Multiple Myeloma ‐ Spleen Tyrosine Kinase (SYK) influences multiple myeloma cell survival and migration
What's in a name? The pharmacy of vitamin K
A common genetic variant in 19q13·3 is associated with outcome of multiple myeloma patients treated with Total Therapy 2 and 3
Effect of five therapeutic strategies on the coagulation defect induced by the thrombomodulin c.1611C>A mutation